Skip to main content

Find Clinical Trials

Clinical trial condition

HCC

Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.

97 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

HCC trial results

Not Yet Recruiting

Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC

NCT07722741

Conditions: HCC
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Not Yet Recruiting

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

NCT07379489

Conditions: Adjuvant Therapy, Disease Attributes, HCC, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3

NCT07353333

Conditions: HCC, SPECT-CT
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07350824

Conditions: Disease Attributes, HCC, Minimal Residual Disease, +6 more
Locations: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular

NCT07352007

Conditions: HCC
Locations: ShandongShandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension

NCT07350070

Conditions: Digestive System Diseases, Fibrosis, HCC, +6 more
Locations: Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology Fuzhou, Fujian, China

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

Hubei Province Tahe Hospital Taihe, Hubei, China

Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

NCT07340502

Conditions: HCC
Locations: Not specified

View Trial Details

Not Yet Recruiting

Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment

NCT07168668

Conditions: HCC, Immunotherapy, TACE
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study Evaluating HAIC Combined With Iparomlimab and Tuvonralimab Injection Plus Bevacizumab in Patients With Initially Potentially Resectable Hepatocellular Carcinoma (ITBHaic Study)

NCT07119931

Conditions: HCC
Locations: Not specified

View Trial Details

Not Yet Recruiting

Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

NCT07007286

Conditions: HBV, HCC
Locations: Qitaihe Infectious Disease Hospital Heilongjiang, China

Yizheng People's Hospital Yizheng, Jiangsu, China

Changle County People's Hospital Changle, Shandong, China

Juxian People's Hospital Junxian, Shandong, China

View all 555 locations

View Trial Details